|
production of molecular mediator of immune response
|
GO_0002440 |
[The synthesis or release of any molecular mediator of the immune response, resulting in an increase in its intracellular or extracellular levels.] |
|
mitochondrial ncRNA surveillance
|
GO_0035945 |
[The set of processes involved in identifying and degrading defective or aberrant non-coding RNA transcripts (ncRNAs) within the mitochondrion.] |
|
ganglioside GM2 binding
|
GO_1905574 |
[Binding to ganglioside GM2.] |
|
ganglioside binding
|
GO_0035594 |
[Binding to a ganglioside, a ceramide oligosaccharide carrying in addition to other sugar residues, one or more sialic acid residues.] |
|
ganglioside GM3 binding
|
GO_1905575 |
[Binding to ganglioside GM3.] |
|
obsolete positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter
|
GO_0035948 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of gluconeogenesis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
|
ganglioside GM1 transport to membrane
|
GO_1905572 |
[The directed movement of ganglioside GM1 to membrane.] |
|
obsolete positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter
|
GO_0035949 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of gluconeogenesis by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
|
ganglioside GM1 binding
|
GO_1905573 |
[Binding to ganglioside GM1.] |
|
regulation of ERBB3 signaling pathway
|
GO_1905578 |
[Any process that modulates the frequency, rate or extent of ERBB3 signaling pathway.] |
|
negative regulation of ERBB3 signaling pathway
|
GO_1905579 |
[Any process that stops, prevents or reduces the frequency, rate or extent of ERBB3 signaling pathway.] |
|
ganglioside GT1b binding
|
GO_1905576 |
[Binding to ganglioside GT1b.] |
|
ganglioside GP1c binding
|
GO_1905577 |
[Binding to ganglioside GP1c.] |
|
mineralocorticoid secretion
|
GO_0035931 |
[The regulated release of any mineralocorticoid into the circulatory system. Mineralocorticoids are a class of steroid hormones that regulate water and electrolyte metabolism.] |
|
corticosteroid hormone secretion
|
GO_0035930 |
[The regulated release of any corticosteroid hormone into the circulatory system.] |
|
aldosterone secretion
|
GO_0035932 |
[The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.] |
|
androgen secretion
|
GO_0035935 |
[The regulated release of an androgen into the circulatory system. Androgens are steroid hormones that stimulate or control the development and maintenance of masculine characteristics in vertebrates.] |
|
positive regulation of low-density lipoprotein particle clearance
|
GO_1905581 |
[Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.] |
|
testosterone secretion
|
GO_0035936 |
[The regulated release of testosterone into the circulatory system. Testosterone is an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.] |
|
response to mannose
|
GO_1905582 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.] |